Naito, C.; Katsumi, H.; Yoneto, K.; Omura, M.; Nishidono, M.; Kamei, S.; Mizoguchi, A.; Tamba, A.; Tanaka, A.; Morishita, M.;
et al. Development of a Phosphoric Acid-Mediated Hyaluronic Acid Gel Sheet for Efficient Transdermal Delivery of Alendronate for Anti-Osteoporotic Therapy. Pharmaceutics 2019, 11, 643.
https://doi.org/10.3390/pharmaceutics11120643
AMA Style
Naito C, Katsumi H, Yoneto K, Omura M, Nishidono M, Kamei S, Mizoguchi A, Tamba A, Tanaka A, Morishita M,
et al. Development of a Phosphoric Acid-Mediated Hyaluronic Acid Gel Sheet for Efficient Transdermal Delivery of Alendronate for Anti-Osteoporotic Therapy. Pharmaceutics. 2019; 11(12):643.
https://doi.org/10.3390/pharmaceutics11120643
Chicago/Turabian Style
Naito, Chihiro, Hidemasa Katsumi, Kunio Yoneto, Mao Omura, Mayuko Nishidono, Sachi Kamei, Akiya Mizoguchi, Ayaka Tamba, Akiko Tanaka, Masaki Morishita,
and et al. 2019. "Development of a Phosphoric Acid-Mediated Hyaluronic Acid Gel Sheet for Efficient Transdermal Delivery of Alendronate for Anti-Osteoporotic Therapy" Pharmaceutics 11, no. 12: 643.
https://doi.org/10.3390/pharmaceutics11120643
APA Style
Naito, C., Katsumi, H., Yoneto, K., Omura, M., Nishidono, M., Kamei, S., Mizoguchi, A., Tamba, A., Tanaka, A., Morishita, M., & Yamamoto, A.
(2019). Development of a Phosphoric Acid-Mediated Hyaluronic Acid Gel Sheet for Efficient Transdermal Delivery of Alendronate for Anti-Osteoporotic Therapy. Pharmaceutics, 11(12), 643.
https://doi.org/10.3390/pharmaceutics11120643